Isolation and identification of SARS-CoV-2 antibodies from COVID-19 patient samples
<p>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is the causing agent for COVID-19, has led to over 7 million deaths since it was first detected in Wuhan, China in December 2019. Antibodies induced by both vaccination and infection are crucial for the immune protection ag...
Main Author: | Liu, C |
---|---|
Other Authors: | Screaton, GR |
Format: | Thesis |
Language: | English |
Published: |
2024
|
Subjects: |
Similar Items
-
SARS-CoV-2 neutralizing antibodies in patients with varying severity of acute COVID-19 illness
by: Jeewandara, C, et al.
Published: (2021) -
Cross-reactive immunity to SARS-CoV-2 and related coronaviruses
by: Jay, C
Published: (2023) -
Studies on immunoreceptor activation and SARS-CoV-2 RBD/ACE2 interactions
by: Barton, MI
Published: (2022) -
Increasing Sporadic Covid-19 Cases:Should We Heed Airborne Transmission Of SARS-CoV-2?
by: Ahmad Mahfuz, Gazali
Published: (2021) -
Characterisation of HBV and SARS-CoV-2 spike specific T cells and their association with viral control
by: Liu, G
Published: (2023)